Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study
- PMID: 20452252
- DOI: 10.1016/j.tripleo.2010.02.020
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study
Abstract
Objectives: The aim of this study was to evaluate the 2-year success rate of management of patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ).
Study design: A prospective study was performed. Positive outcome variables were the resolution of symptoms and the status of the mucosa.
Results: A total of 37 patients are described. The precipitating event was a dental extraction in 22 cases (59.5%). Thirteen patients (35.1%) underwent surgery, and 24 (64.9%) underwent antimicrobial therapy alone. After 2 years, 20 patients (54.1%) presented with soft tissue closure over previously exposed bone, and there were no statistical differences in gender, age, bisphosphonate treatment, or treatment modalities. Spontaneous lesions seemed to have a worse prognosis (P = .001).
Conclusions: Initial antimicrobial treatment, and later surgery for unresponsive patients, might be a feasible treatment modality for BRONJ. Because these results are not conclusive, it would be very interesting to know if this statement would be the same with a greater number of patients.
Copyright (c) 2010 Mosby, Inc. All rights reserved.
Similar articles
-
Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.J Oral Maxillofac Surg. 2010 May;68(5):1055-63. doi: 10.1016/j.joms.2009.12.030. J Oral Maxillofac Surg. 2010. PMID: 20403529
-
Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.Int J Oral Maxillofac Surg. 2011 Mar;40(3):277-84. doi: 10.1016/j.ijom.2010.11.002. Epub 2010 Dec 15. Int J Oral Maxillofac Surg. 2011. PMID: 21163625
-
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051. J Oral Maxillofac Surg. 2009. PMID: 19686928
-
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Minerva Stomatol. 2010. PMID: 20360666 Review. English, Italian.
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
Cited by
-
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.Front Oncol. 2022 Aug 30;12:927685. doi: 10.3389/fonc.2022.927685. eCollection 2022. Front Oncol. 2022. PMID: 36110957 Free PMC article.
-
Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw.J Korean Assoc Oral Maxillofac Surg. 2018 Oct;44(5):225-231. doi: 10.5125/jkaoms.2018.44.5.225. Epub 2018 Oct 26. J Korean Assoc Oral Maxillofac Surg. 2018. PMID: 30402414 Free PMC article.
-
The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla.Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17(2):e236-41. doi: 10.4317/medoral.17422. Med Oral Patol Oral Cir Bucal. 2012. PMID: 22143692 Free PMC article.
-
Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.Int J Oral Sci. 2020 Oct 21;12(1):30. doi: 10.1038/s41368-020-00093-2. Int J Oral Sci. 2020. PMID: 33087699 Free PMC article. Review.
-
Oral squamous cell carcinoma arising in a patient after hematopoietic stem cell transplantation with bisphosphonate-related osteonecrosis of the jaws.Case Rep Dent. 2015;2015:831418. doi: 10.1155/2015/831418. Epub 2015 Apr 20. Case Rep Dent. 2015. PMID: 25973278 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical